(Q84094992)
Statements
Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization (English)
Shmuel H Klang
Ariel Hammerman
Nicky Liebermann
Noa Efrat
Julie Doberne
John Hornberger
15 April 2010